Clinical Trial Update: Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis [NA]

View source ↗

Summary

A follow-up study evaluating autologous transplantation of P63+ lung progenitor cells for bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• Autologous P63+ Lung Progenitor Cell Transplant (autologous P63+ lung progenitor cell therapy)

Snippet

Sponsor: Ruijin Hospital | Conditions: Bronchiectasis | NA | Status: COMPLETED